Please enable Javascript
Uromigos Live and Unplugged
Advertisement
The Uromigos Live & Unplugged: New Perspectives on GU Cancer
Michael R. Page, PharmD, RPh
Journal
|
December 19, 2022
The Uromigos: Live & Unplugged event incorporated presentations and discussions in the field of urologic malignancies.
Read More
Michael Whitley on Understanding Cancer Through The Uromigos
The Uromigos
Uromigos Live and Unplugged
|
November 16, 2022
Cancer patient Michael Whitley explains how The Uromigos help him understand new prostate cancer treatments and research.
View More
Matthew Tucker Tells Us His Favorite Uromigos Episodes
The Uromigos
Uromigos Live and Unplugged
|
November 11, 2022
Matthew Tucker, MD from Grandview Cancer Center talks about why he enjoys The Uromigos and what his favorite episodes are.
View More
Chandler Park Gives a Shoutout to The Uromigos
The Uromigos
Uromigos Live and Unplugged
|
November 11, 2022
Chandler Park, MD from University of Louisville Hospital talks about why he recommends The Uromigos podcast.
View More
Petros Grivas on the Efficacy of Sacituzumab Govitecan for Bladder Cancer
The Uromigos
Uromigos Live and Unplugged
|
November 11, 2022
Petros Grivas, MD, PhD, Director of UW Medicine's GU Cancers Program, talks about the efficacy of sacituzumab govitecan.
View More
Shilpa Gupta on Maintenance Therapy for Bladder Cancer
The Uromigos
Uromigos Live and Unplugged
|
November 11, 2022
Shilpa Gupta, MD discusses maintenance therapy for bladder cancer, including the current standard of care and ongoing trials.
View More
Thomas Powles on The Uromigos: Live & Unplugged Bladder Cancer Session
The Uromigos
Uromigos Live and Unplugged
|
November 11, 2022
Thomas Powles, MBBS, MRCP, MD gives an overview of highlights from The Uromigos: Live & Unplugged bladder cancer session.
View More
Matthew Galsky on Adjuvant Nivolumab Trials
The Uromigos
Uromigos Live and Unplugged
|
November 11, 2022
Matthew Galsky, MD gives insight on adjuvant nivolumab trials, including use in unselected patients and overall survival.
View More
Kala Sridhar on Bladder-Sparing Treatment for Urothelial Carcinoma
The Uromigos
Uromigos Live and Unplugged
|
November 15, 2022
Kala Sridhar talks about bladder-sparing treatments for urothelial carcinoma and how patient populations are shifting.
View More
Jonathan Rosenberg on Enfortumab Vedotin for Urothelial Carcinoma
The Uromigos
Uromigos Live and Unplugged
|
November 11, 2022
Jonathan Rosenberg, MD talks about the development of enfortumab vedotin, including monotherapy info and combination data.
View More
Christopher Sweeney on ADT Combination Therapies for Prostate Cancer
The Uromigos
Uromigos Live and Unplugged
|
November 28, 2022
Christopher Sweeney talks about prostate cancer trials investigating the use of ADT + docetaxel or cabazitaxel.
View More
Christopher Sweeney on the Future of Prostate Cancer Care
The Uromigos
Uromigos Live and Unplugged
|
November 28, 2022
Christopher Sweeney, MBBS, gives us his insight on the future of prostate cancer care and research in the year 2027.
View More
Nick James on the Future of Prostate Cancer Care
The Uromigos
Uromigos Live and Unplugged
|
November 11, 2022
Nick James, MBBS, PhD, FRCP, FRCR, discusses his outlook on the future of prostate cancer treatment in the year 2027.
View More
Daniel George on the Future of mHSPC Treatment
The Uromigos
Uromigos Live and Unplugged
|
October 12, 2023
Daniel George, MD, Duke University School of Medicine, gives us insight on what to expect from the future of mHSPC treatment.
View More
Neeraj Agarwal on the Future of mHSPC Treatment
The Uromigos
Uromigos Live and Unplugged
|
October 12, 2023
Neeraj Agarwal, MD, Professor of Medicine, gives his outlook on the future of cancer care and treatment for mHSPC in 2027.
View More
Sumanta Pal on New Treatments and TiNivo-2 for RCC
The Uromigos
Uromigos Live and Unplugged
|
November 11, 2022
Sumanta Pal, MD, FASCO, from City of Hope talks about new drugs and the ongoing TiNivo-2 trial for renal cell carcinoma.
View More
David McDermott on RCC Therapies and Treatment
The Uromigos
Uromigos Live and Unplugged
|
November 11, 2022
David McDermott, MD talks about monotherapy and combination therapy for RCC and future advances in RCC treatment.
View More
Rana McKay on the Future of Prostate Cancer Care
The Uromigos
Uromigos Live and Unplugged
|
November 11, 2022
Rana McKay, MD, GU Medical Oncologist from UCSD, gives her outlook on the future of prostate cancer care in the year 2025.
View More
Michael Morris on the Future of mHSPC Treatment
The Uromigos
Uromigos Live and Unplugged
|
October 12, 2023
Michael Morris, MD, of Memorial Sloan Kettering Cancer Center gives his predictions for the future of mHSPC treatment.
View More
The Uromigos: Prostate Cancer Hot Topics Buzzer Round
The Uromigos
Uromigos Live and Unplugged
|
November 10, 2022
Featuring panelists Neeraj Agarwal, MD, Daniel George, MD, Nick James, MBBS, PhD, FRCP, FRCR, Rana McKay, MD, and more.
View More
Load More
Advertisement
Advertisement
Advertisement